Uso de agentes estimuladores de la eritropoyesis en pacientes con insuficiencia cardiaca congestiva

descriptionPublicationkeyboard_double_arrow_right Article 01 Mar 2014 Spanish Publisher:Elsevier BVJournal:Medicina Clínica, volume 142, pages 215-218 (issn: 0025-7753,

Copyright policy )

Authors: Nicolás Roberto Robles Perez-Monteoliva; Juan Francisco Macías Núñez; Julio Herrera Pérez de Villar;

doi: 10.1016/j.medcli.2013.06.014

Uso de agentes estimuladores de la eritropoyesis en pacientes con insuficiencia cardiaca congestiva

- Summary
- Metrics

Abstract

Congestive heart failure is a disease of high incidence and prevalence in the elderly. Anemia is associated with an increased mortality in these patients. This article reviews the cumulated evidence about the use of erythropoiesis-stimulating agents in congestive heart failure patients. Although some improvement in quality of life has been shown, it has not been found any decrement on mortality and, as a result, together with the high drug cost, it is not recommended the use of this kind of drugs in heart failure patients.

Related Organizations

University of Salamanca
Spain

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average